The Best Crossword Puzzle Maker Online
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crossword Word Search Worksheet
Rate This Puzzle:
Log in or sign up to rate this puzzle.

Kcentra

Across
Kcentra is FDA indicated to reverse the effects of
The incidence of TEE were ____ in both Kcentra and FFP per the package insert
Kcentra is supplied in a single
Kcentra is capped at what weight in kg
What should be administered concurrently with Kcentra
The dosing of Kcentra is determined by the patient's body weight and baseline
Kcentra has a boxed warning for arterial and venous ______ complications
Kcentra is composed of factors II, VII, IX, X and Proteins __ and __
This is the number of months Kcentra is stable
Kcentra may not be suitable in patients with TEE in the prior ____ months
Down
Kcentra must be used within ____ hours following administration
There were no clinically significant differences found in the safety profile of Kcentra and Plasma when this population was evaluated
The primary end point in the RCT looked at what type of efficacy
Kcentra demonstrated _____ in early INR reduction to less than or equal to 1.3 thirty minutes after end of infusion
Kcentra is made from
The most serious ARs reported in the RCT
List one common adverse reaction
Kcentra contains ____ dependent clotting factors
The safety and efficacy of Kcentra has not been studied in this population
This endpoint looked at reduction of INR to less than or equal to 1.3 at how many minutes after end of infusion
Kcentra is contraindicated in patients with a history of
The factor ____ value is used to determine the actual units of Kcentra per vial
Kcentra is also contraindicated in this serious medical condition
Kcentra should never be